Log In
BCIQ
Print this Print this
 

Dermacyn Wound, Microcyn60 (Dermacyn, Microcyn)

  Manage Alerts
Collapse Summary General Information
Company Sonoma Pharmaceuticals Inc.
DescriptionSolution containing oxychlorine compounds
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationWounds
Indication DetailsTreat chronic wounds including ulcers, cuts, contusions and burns
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$5.1M

$5.1M

0


 Deals Details
Get a free BioCentury trial today